First In-Situ Long Term ‘Implant’ Decontamination Contract Win in an NHS Hospital
17 January 2008
BIOQUELL announces that Gloucestershire Hospitals NHS Foundation Trust is the first hospital trust in the UK to deploy a BIOQUELL 'implant' team on a preventative basis, to combat hospital-acquired infection.
The BIOQUELL implant team comprises of an onsite team of highly-trained BIOQUELL engineers and specialist, proprietary hydrogen peroxide vapour sterilisation equipment which is used to decontaminate rooms or equipment in a hospital on a preventative basis against 'superbugs' including Clostridium difficile, MRSA, Acinetobacter, VRE or norovirus.
Commenting on this long term contract win, Nick Adams, Chief Executive of BIOQUELL PLC said: "After a decade of research and development into the decontamination of 'superbugs' and sterilisation of rooms containing sensitive electronic equipment, we are delighted to see BIOQUELL's unique hydrogen peroxide vapour technology being deployed in a proactive manner against hospital acquired infection in the UK."
Further information on the deployment of BIOQUELL's technology against hospital acquired infection in NHS hospitals is available on the Department of Health's web site.
